CRISPR Therapeutics AG (CRSP) Current Deferred Revenue (2016 - 2026)
CRISPR Therapeutics AG (CRSP) reported Current Deferred Revenue of $15.19 million for Q2 2026, up 613.4% from $2.13 million a year earlier but down 1.0% from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Current Deferred Revenue (2016 - 2026) Analysis & Trends
At the end of FY2025, CRISPR Therapeutics AG posted Current Deferred Revenue of $15.77 million, up 310.2% from FY2024.
- Current Deferred Revenue has a five-year compound annual growth rate of 46.5% (FY2020 to FY2025).
- By year, Current Deferred Revenue came in at $3.85 million in FY2024 (-6.3%), $4.11 million in FY2023 and $1.01 million in FY2021 (-56.8%).
- Five-year quarterly Current Deferred Revenue spans a low of $1.01 million in Q4 2021 and a high of $15.77 million in Q4 2025.
- Year over year, Current Deferred Revenue has now increased in each of the last three quarters, with growth averaging 150.1% over the last eight quarters.
- The high point for year-over-year Current Deferred Revenue in five years was Q2 2026 (growth of 613.4%); the low point was Q3 2025 (a decline of 71.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $15.34 million (Q1 2026), $15.77 million (Q4 2025) and $1.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | CRISPR Therapeutics AG | 4.81 Bn | -3.89 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.19 Mn |
| Mar 31, 2026 | 15.34 Mn |
| Dec 31, 2025 | 15.77 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 2.13 Mn |
| Mar 31, 2025 | 3.02 Mn |
| Dec 31, 2024 | 3.85 Mn |
| Sep 30, 2024 | 4.48 Mn |
| Jun 30, 2024 | 4.76 Mn |
| Mar 31, 2024 | 4.07 Mn |
| Dec 31, 2023 | 4.11 Mn |
| Sep 30, 2023 | 3.50 Mn |
| Dec 31, 2021 | 1.01 Mn |
| Sep 30, 2021 | 1.56 Mn |
| Jun 30, 2021 | 2.07 Mn |
| Mar 31, 2021 | 1.80 Mn |
| Dec 31, 2020 | 2.34 Mn |
| Sep 30, 2020 | 610,000.00 |
| Jun 30, 2020 | 759,000.00 |
| Mar 31, 2020 | 803,000.00 |
API Access
CRISPR Therapeutics AG Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();